Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19
2021 · JAMA · 209 citations
https://doi.org/10.1001/jama.2021.18178
J
Jeffrey Presneill
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
190
Papers
9.8K
Citations
45
h-index
97
i10-index
Jeffrey Presneill is an academic researcher from The Royal Melbourne Hospital. The author has contributed to research in topics: Intensive Care Unit Cognitive Disorders & Sepsis Diagnosis and Treatment & Respiratory Support and Mechanisms. The author has an h-index of 45, co-authored 162 publications.
ORCID: 0000-0001-7177-7667Papers by this author
worksA randomized trial of protocol-directed sedation management for mechanical ventilation in an Australian intensive care unit*
2008 · Critical Care Medicine · 187 citations
https://doi.org/10.1097/ccm.0b013e318168f82d
Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19
2022 · JAMA · 149 citations
https://doi.org/10.1001/jama.2022.2910
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
2022 · JAMA · 134 citations
https://doi.org/10.1001/jama.2022.23257
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
2021 · Intensive Care Medicine · 96 citations
https://doi.org/10.1007/s00134-021-06448-5
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
2021 · Intensive Care Medicine · 96 citations
https://doi.org/10.1007/s00134-021-06448-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat